Rina Irene Fermont has dedicated her career to patient’s safety. As a physician, Immuno-hematologist, she started with the setup of the Bone Marrow Graft unit in the Versailles Blood Bank and implemented a first of its kind experience in the Hopital de l’Ouest Parisien: implementing procedures and several autotransfusion techniques, educating the whole staff led to decrease blood transfusions by 50% within a year.

Completing her education with a Master in Bioengineering in Ecole Centrale Paris, she initiated large projects such as turnkey blood banks for developing countries and worked with Hebrew University technology transfer.

For more than 20 years, she created and managed Pharmacovigilance and Risk Management departments or companies at international level. Struck by the crisis she managed with a Low Molecular Weight Heparin, she created the working group on Misuse and Medication Error, gathering Pharmacovigilance centres, industry and authorities, whose results were included in the French Good Pharmacovigilance Practices, several years before the European guidelines.

Irene is the founder and director of her own consulting company IFC in Israel, France and UK. Pioneering risks prevention, teaching on Risk Management, advocating multisciplinary and system approach, proposing new concepts, her passion led to the creation of the Israeli Chapter of ISOP, the International Society of Pharmacovigilance in 2013. Teaching and conceiving new projects to address unmet medication safety issues are her main drivers, in international congresses, in several countries and in Israel for more than 10 years. She is an active member of the ISOP Working Group on Risk Communication.